ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
Galapagos

Galapagos (GLPG)

25.58
0.04
(0.16%)
終了 12月22日 1:30AM

個人投資家向けのプロ仕様のツール。

主要統計と詳細

通貨
25.58
買値
24.90
売値
25.64
出来高
119,487
24.90 日の範囲 25.58
22.00 52 週間の範囲 39.00
時価総額
前日終値
25.54
始値
25.52
最終取引時間
財務取引量
-
VWAP
-
平均取引量 (3 か月)
88,488
発行済株式数
65,897,000
配当利回り
-
PER
7.96
1 株当たり利益 (EPS)
3.21
歳入
843.8M
純利益
211.7M

Galapagos について

セクター
Coml Physical, Biologcl Resh
業界
Coml Physical, Biologcl Resh
ウェブサイト
本社
Mechelen, Antwerp, Bel
設立
-
Galapagos is listed in the Coml Physical, Biologcl Resh sector of the ユーロネクスト with ticker GLPG. The last closing price for Galapagos was 25.54 €. Over the last year, Galapagos shares have traded in a share price range of 22.00 € to 39.00 €.

Galapagos currently has 65,897,000 shares in issue. The market capitalisation of Galapagos is 1.68 € billion. Galapagos has a price to earnings ratio (PE ratio) of 7.96.

GLPG 最新ニュース

Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma

Data from the ongoing Phase 1/2 ATALANTA-1 study in a heavily pretreated R/R NHL patient population demonstrate high antitumor activity and an encouraging safety profile in all NHL subtypes...

Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma

Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma Data from the ongoing Phase...

Galapagos to Present Results of Pioneering Innovation in Cancer Cell Therapy at ASH 2024

Galapagos to Present Results of Pioneering Innovation in Cancer Cell Therapy at ASH 2024 New Phase 1/2 data support the potential of our CAR T-cell therapy candidates, GLPG5101 and GLPG5201, in...

Galapagos to Present Results of Pioneering Innovation in Cancer Cell Therapy at ASH 2024

New Phase 1/2 data support the potential of our CAR T-cell therapy candidates, GLPG5101 and GLPG5201, in addressing unmet needs for patients with poor prognoses. Our innovative decentralized cell...

Galapagos Reports Third Quarter 2024 Financial Results and Provides Business Update

Galapagos Reports Third Quarter 2024 Financial Results and Provides Business Update We are advancing our pipeline and accelerating innovation through focused execution of our Forward, Faster...

Galapagos Reports Third Quarter 2024 Financial Results and Provides Business Update

We are advancing our pipeline and accelerating innovation through focused execution of our Forward, Faster strategy.We are committed to addressing the high unmet needs of patients through a...

Galapagos welcomes Oleg Nodelman to its Board of Directors to support strategic growth

Mechelen, Belgium; October 7, 2024, 07:00 CET — Galapagos NV (Euronext & NASDAQ: GLPG), today announced the appointment by way of co-optation of Oleg Nodelman as Non-Executive Non-Independent...

Galapagos welcomes Oleg Nodelman to its Board of Directors to support strategic growth

Galapagos welcomes Oleg Nodelman to its Board of Directors to support strategic growth Mechelen, Belgium; October 7, 2024, 07:00 CET — Galapagos NV (Euronext & NASDAQ: GLPG), today announced...

Galapagos receives transparency notification from EcoR1 Capital

Galapagos receives transparency notification from EcoR1 Capital Mechelen, Belgium; 30 September 2024, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a...

Galapagos receives transparency notification from EcoR1 Capital

Mechelen, Belgium; 30 September 2024, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification from EcoR1 Capital LLC. Pursuant to Belgian...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.24-0.92951200619725.8225.8224.97412725.57215267DE
41.586.583333333332426.8247459725.77000217DE
12-0.7-2.6636225266426.2828.6823.668848825.95250232DE
261.225.0082101806224.3628.68229363825.372968DE
52-10.56-29.219701162136.1439228913427.83389873DE
156-21.92-46.147368421147.566.282215988442.81187068DE
260-161.52-86.3281667557187.1252.92228408490.30539587DE

GLPG - Frequently Asked Questions (FAQ)

What is the current Galapagos share price?
The current share price of Galapagos is 25.58 €
How many Galapagos shares are in issue?
Galapagos has 65,897,000 shares in issue
What is the market cap of Galapagos?
The market capitalisation of Galapagos is EUR 1.68B
What is the 1 year trading range for Galapagos share price?
Galapagos has traded in the range of 22.00 € to 39.00 € during the past year
What is the PE ratio of Galapagos?
The price to earnings ratio of Galapagos is 7.96
What is the cash to sales ratio of Galapagos?
The cash to sales ratio of Galapagos is 2
What is the reporting currency for Galapagos?
Galapagos reports financial results in EUR
What is the latest annual turnover for Galapagos?
The latest annual turnover of Galapagos is EUR 843.8M
What is the latest annual profit for Galapagos?
The latest annual profit of Galapagos is EUR 211.7M
What is the registered address of Galapagos?
The registered address for Galapagos is GENERAAL DE WITTELAAN L11, MECHELEN, ANTWERP, A3 2800
What is the Galapagos website address?
The website address for Galapagos is www.glpg.com
Which industry sector does Galapagos operate in?
Galapagos operates in the COML PHYSICAL, BIOLOGCL RESH sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
TMBSZTME Pharma NV
0.02 €
(185.71%)
132.5k
MLGEQGentlemen S Equity SA
0.0175 €
(118.75%)
1.14k
ALCYBCybergun
0.0002 €
(100.00%)
17.54M
MLAAHAmatheon Agri Holding NV
0.0185 €
(54.17%)
40.1k
ALARFAdeunis
0.94 €
(28.77%)
5.27k
MLSMLSmalto
0.0125 €
(-37.50%)
2.34k
MLFTIFrance Tourisme Immobilier
0.025 €
(-35.90%)
56.77k
CNVCnova NV
0.209 €
(-19.62%)
26.38k
MLWEAWeaccess Group
0.382 €
(-16.96%)
5.95k
ALEUPEuroplasma
0.0353 €
(-15.95%)
3.16M
ATOAtos SE
0.0021 €
(0.00%)
2.71B
BCPBanco Comercial Portugues SA
0.4493 €
(-0.69%)
66.54M
ALHGLouis Hachette Group
1.3342 €
(4.87%)
52.04M
KPNKoninklijke KPN NV
3.509 €
(-1.21%)
26.9M
VIVVivendi SE
2.51 €
(2.41%)
26.39M

最近閲覧した銘柄

Delayed Upgrade Clock